Psychedelic Stocks Archives - Page 27 of 61

FridayJun 09, 2023 1:46 pm

Largest Phase 3 Clinical Trial on Psilocybin Gets Underway

Researchers from Compass Pathways PLC (NASDAQ: CMPS) have commenced the largest-ever phase 3 clinical trial investigating the effectiveness of psilocybin against depression. The mental health company first announced the phase 3 program in late 2022 during an online Capital Markets Day. Compass Pathways’ phase 2b study on the therapeutic potential of psilocybin against depression provided encouraging results and allowed the company to move forward with the next phase of research. Like the recently commenced phase 3 trial, the phase 2b study made history as the largest double-blind, controlled and randomized study of psilocybin therapies. It showed that patients with depression…

ThursdayJun 08, 2023 3:10 pm

Kentucky to Inject $42M into Psychedelic Research

The state of Kentucky joins the growing number of regions that are investing in psychedelics by injecting tens of millions of dollars into researching the therapeutic potential of hallucinogens in substance use disorders. More specifically, Kentucky is investing more than $40 million in psychedelic research as part of its efforts to curb the growing opioid addiction crisis. Kentucky Attorney General Daniel Cameron said in a recent Kentucky Opioid Abatement Advisory Commission (KYOAAC) news conference that the commission wanted to investigate novel treatments for people suffering from opioid use disorder. The commission was formed in 2022 to distribute more than $842…

WednesdayJun 07, 2023 2:12 pm

Bipartisan Bill Proposes $75M Fund for Psychedelics Research for Military Personnel

Psychedelics are currently experiencing a renaissance that could leave them at the top of the psychiatric industry. Over the past couple of years, research has shown that natural and synthetic psychedelics show potential to treat symptoms of various mental health conditions. Although treatments for conditions such as post-traumatic stress disorder, depression and anxiety already exist, those treatments often aren’t effective, and they rarely offer long-term relief. This means that people who are in desperate need of mental health treatment, such as military veterans, rarely receive the treatment they need and often end up dealing with their symptoms in other ways.…

TuesdayJun 06, 2023 3:30 pm

Psychedelics Decriminalization Gives Rise to Community Microdosing in San Francisco

In only a few short years, psychedelics have gone from being criminalized drugs enjoyed by a small niche community to alternative medicines with the psychedelics’ potential to completely revolutionize the psychiatric industry. With initial research indicating that several psychedelics could be potent, safe and effective mental-health treatments for various disorders, lawmakers across the United States are considering relaxing their psychedelic policies. While Denver, Colorado was the first city in the U.S. to decriminalize all psychedelics, other regions are quickly amending their policies to allow the nascent psychedelic industry to flourish. The San Francisco Bay Area, which is somewhat famous among…

MondayJun 05, 2023 2:12 pm

Psychedelics Could Take Palliative Care to New Level

For the longest time, the field of palliative care has been focused on making seriously or terminally ill patients as physically comfortable as possible for the time they have left. This often includes medication to relieve pain, treatments such as surgery and radiation therapy to treat symptoms and side effects, and physical therapy. Although palliative care also includes emotional and spiritual support to help patients cope with the situation, the focus is mostly placed on alleviating physical symptoms and discomforts. However, the psychedelic revolution may finally make it possible for palliative care patients to receive treatment for both their physical…

FridayJun 02, 2023 12:46 pm

EU Parliament Unveils Working Group to Advance Medical Psychedelics

Psychedelics just may be what the mental health field needed to finally develop safe, effective and long-lasting treatments for patients with mental disorders. After decades of criminalization, territories around the world are loosening their psychedelic policies and making it possible for scientists to study the potential medical applications of these substances. Most of this early research has delivered extremely promising results with researchers from around the world finding that several psychedelics can treat disorders such as post-traumatic stress disorder, treatment-resistant depression, anxiety and eating disorders. Lawmakers are now working to expand psychedelic policies and give researchers more room to study…

ThursdayJun 01, 2023 1:28 pm

Colorado Governor Ratifies Law Establishing Rules for Using Psychedelics

Like medical cannabis a few years ago, psychedelics have now captured the public consciousness due to their medical potential. Research into psychedelics has revealed that they can treat many mental health disorders with minimal side effects. With millions of Americans currently struggling with mental health conditions, psychedelic-assisted therapies couldn’t have come at a better time. Although the psychedelic reform movement is still in its infancy, it is steadily picking up steam within American cities and states. Colorado Governor Jared Polis recently signed a law that would create a regulatory system for the use of psychedelic substances in “licensed healing centers.”…

WednesdayMay 31, 2023 12:04 pm

UK Lawmakers Advocate for Reforms to Psychedelics Laws

The United Kingdom may be the latest Western country to pass psychedelic reform if UK lawmakers have their way. In countries such as the United States, Canada and Australia, permissive psychedelic policies have made it possible for researchers to study the potential benefits and risks of psychedelic drugs. This research has revealed that hallucinogens including psilocybin, MDMA and LSD may be able to treat the symptoms of a range of mental health disorders. A recent report by Benzinga revealed that UK Labor MP Charlotte Nichols has “opened up a discussion’ on the need to increase access to psychedelic-assisted therapies. The…

TuesdayMay 30, 2023 1:51 pm

Study Shows LSD Analog’s Potential for Treating Mood Disorders

A recent study has indicated that a nonhallucinogenic form of LSD may be able to treat mood disorders. LSD is one of several psychedelics that have recently gained attention from the scientific community as potential treatments for mental health conditions. Initial psychedelic studies have provided positive results, with researchers finding that hallucinogens such as psilocybin, LSD and MDM can potentially treat a wide variety of psychiatric disorders. However, psychedelic therapies are marred by the fact that patients have to go through mind-bending psychedelic experiences during treatment, often for hours at a time. This hikes the cost of psychedelic therapy because…

FridayMay 26, 2023 11:14 am

Canadian Survey Reveals Valuable Insights About Psychedelics

Apart from brief research that was carried out in the 1960s, scientists don’t know a lot about the underlying mechanisms that allow psychedelics to deliver their mental health benefits. To help bridge this crucial knowledge gap, several institutions have teamed up to survey the Canadian public on psychedelics. Called the Canadian Psychedelic Survey (CPS), the poll was cosponsored by Psygen Industries, SABI Mind and MAPS PBC, and designed with the aid of academic researchers from top universities and clinicians. The 655-question survey was mainly concerned with collecting data on the characteristics of psychedelics, their patterns of use and public access…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000

Category: Psychedelic Stocks